Advertisement

Author: Janine Anthes

Tolvaptan Safe & Effective in Real-World Setting

With limited real-world data on the safety and efficacy of tolvaptan since its approval to treat ADPKD in 2014, investigators conducted post-marketing surveillance to evaluate the long-term safety and efficacy of the agent in...

Read More

Tackling eGFR Decline in Patients with ADPKD

Initiating or maintaining tolvaptan therapy significantly delayed estimated glomerular filtration rate (eGFR) decline in patients with baseline eGFR of 15-24 and 25-29 ml/min per 1.73 m2, according to a study published in Kidney...

Read More

Locum Tenens: A Solution to Physician Burnout?

As the shortage of experienced and skilled physicians continues to grow nationwide, so will cases of physician burnout. There simply aren’t enough physicians and enough hours in the day to cover all the needs. After many years...

Read More

Enrollment: Infusion Therapy Edition

Location Name* Address* Street Address Address Line 2 City State / Province / Region ZIP / Postal Code Country AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and...

Read More

For latest news and updates
Email-id is invalid